ArticleThe British journal of dermatology2020
Psoriasis Area and Severity Index vs. pharmacokinetics: can monitoring 4-week postinjection ustekinumab concentrations in patients with suboptimal response be clinically relevant?
L PuigPubMed ↗Publisher ↗
No numbers read from the abstract.